These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 9235668)
1. [The current strategy for pathogenetic therapy in systemic scleroderma]. Guseva NG Ter Arkh; 1997; 69(5):79-81. PubMed ID: 9235668 [No Abstract] [Full Text] [Related]
2. [The evolution of juvenile systemic scleroderma]. Starovoĭtova MN; Guseva NG Ter Arkh; 1997; 69(11):55-60. PubMed ID: 9483750 [TBL] [Abstract][Full Text] [Related]
3. [The evolution of the concepts of systemic scleroderma]. Guseva NG Ter Arkh; 1995; 67(5):50-3. PubMed ID: 7638781 [No Abstract] [Full Text] [Related]
4. [Physical factors in the pathogenetic therapy of children with scleroderma]. Popik GS; Riabova TV; Martynovets LV; Kolesnikova TV Vopr Kurortol Fizioter Lech Fiz Kult; 1990; (4):46-8. PubMed ID: 2275105 [TBL] [Abstract][Full Text] [Related]
5. [A case of a combination of systemic scleroderma with diffuse eosinophilic fasciitis]. Krasovskiĭ II; Shkodkin IV; Vladimirova NN Ter Arkh; 1996; 68(9):84-5. PubMed ID: 9005625 [No Abstract] [Full Text] [Related]
6. [A case of the successful treatment of true scleroderma kidney]. Nikolaev AIu; Milovanov IuS; Bezruk VG; Trofimova EI; Dzgoeva FU Klin Med (Mosk); 1995; 73(3):104-5. PubMed ID: 8577092 [No Abstract] [Full Text] [Related]
7. [Treatment problems in systemic scleroderma using hyperbaric oxygenation]. Lukich VL; Grebenev AL; Matrenitskaia NA; Grabskiĭ MA Klin Med (Mosk); 1984 Mar; 62(3):26-31. PubMed ID: 6716924 [No Abstract] [Full Text] [Related]
8. [The clinical picture and therapy of progressive systemic scleroderma]. Sönnichsen N; Brenke A; Witt C Dtsch Med Wochenschr; 1992 Mar; 117(11):427-31. PubMed ID: 1544345 [No Abstract] [Full Text] [Related]
9. [Complex treatment of different forms of scleroderma]. Braĭtsev AV; Marzeeva GI Vestn Dermatol Venerol; 1974 Jun; 0(6):75-80. PubMed ID: 4423437 [No Abstract] [Full Text] [Related]
10. [Plasmapheresis in systemic sclerosis and polymyositis/dermatomyositis]. Matsuda M Nihon Rinsho; 2004 May; 62 Suppl 5():568-71. PubMed ID: 15197986 [No Abstract] [Full Text] [Related]
11. [Hormonal shifts in children with scleroderma during health resort treatment]. Shliapak EA; Kuznetsov BG; Kevorkov KA; Loksh LL; Gabidova NT Vopr Kurortol Fizioter Lech Fiz Kult; 1985; (6):40-2. PubMed ID: 2935994 [No Abstract] [Full Text] [Related]
12. A case of nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis. Weiss AS; Lucia MS; Teitelbaum I Nat Clin Pract Nephrol; 2007 Feb; 3(2):111-5. PubMed ID: 17251999 [TBL] [Abstract][Full Text] [Related]
13. Scleroderma-like manifestation in a patient with primary systemic amyloidosis: response to high-dose intravenous immunoglobulin and plasma exchange. Cho SB; Park JS; Kim HO; Chung KY Yonsei Med J; 2006 Oct; 47(5):737-40. PubMed ID: 17066519 [TBL] [Abstract][Full Text] [Related]
14. One year in review 2017: systemic sclerosis. Barsotti S; Bruni C; Orlandi M; Della Rossa A; Marasco E; Codullo V; Guiducci S Clin Exp Rheumatol; 2017; 35 Suppl 106(4):3-20. PubMed ID: 29035173 [TBL] [Abstract][Full Text] [Related]
16. [The local therapy of systemic scleroderma]. Guseva NG Ter Arkh; 1990; 62(5):110-3. PubMed ID: 2396204 [No Abstract] [Full Text] [Related]
17. Advances in therapy of systemic sclerosis. Misra R; Khanna D J Assoc Physicians India; 2006 Jun; 54 Suppl():48-51. PubMed ID: 16909717 [No Abstract] [Full Text] [Related]
18. Scleroderma: living with unpredictability. Acorn S; Joachim G; Wachs JE AAOHN J; 2003 Aug; 51(8):353-7; quiz 358-9. PubMed ID: 12934863 [TBL] [Abstract][Full Text] [Related]
19. [The different clinical variants of scleroderma in diabetics]. Khamaganova IV Ter Arkh; 1989; 61(10):70-3. PubMed ID: 2609276 [TBL] [Abstract][Full Text] [Related]
20. [Therapeutic possibilities in systemic scleroderma]. Sönnichsen N; Brenke A Z Arztl Fortbild (Jena); 1992 Mar; 86(5):227-30. PubMed ID: 1585676 [No Abstract] [Full Text] [Related] [Next] [New Search]